{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:58:33Z","timestamp":1790373513262,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.lansea.2026.100873","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:58:00Z","timestamp":1790315880000},"page":"100873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: a randomized controlled trial (2023)"],"prefix":"10.1016","volume":"55","author":[{"given":"Thanachote","family":"Arayanumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobporn","family":"Boonnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-8987","authenticated-orcid":false,"given":"Surasak","family":"Kantachuvesiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3194-1511","authenticated-orcid":false,"given":"Sarinya","family":"Boongird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0930-8936","authenticated-orcid":false,"given":"Jackrapong","family":"Bruminhent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lansea.2026.100873_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/14787210.2020.1713098","article-title":"Influenza in solid organ transplant recipients: epidemiology, management, and outcomes","volume":"18","author":"Mombelli","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.lansea.2026.100873_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.transproceed.2013.11.063","article-title":"Comparison of the immunogenicity of a monovalent influenza A\/H1N1 2009 vaccine between healthy individuals, patients with chronic renal failure, and immunocompromised populations","volume":"46","author":"Watcharananan","year":"2014","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.lansea.2026.100873_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.lansea.2026.100873_bib4","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1016\/j.vaccine.2018.08.057","article-title":"Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: a randomized controlled trial","volume":"36","author":"Mombelli","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.lansea.2026.100873_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/TP.0000000000003702","article-title":"An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a Standard-Double-and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients","volume":"106","author":"Odongo","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.lansea.2026.100873_bib6","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lansea.2026.100873_bib7","series-title":"Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials","year":"2007"},{"issue":"1","key":"10.1016\/j.lansea.2026.100873_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/cid\/ciad477","article-title":"Immunogenicity of high-dose versus MF59-Adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the swiss\/spanish trial in solid organ transplantation on prevention of influenza (STOP-FLU trial)","volume":"78","author":"Mombelli","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.lansea.2026.100873_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-158-1-201301010-00005","article-title":"Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-Infected persons: a single-center, parallel, randomized trial","volume":"158","author":"McKittrick","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.lansea.2026.100873_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.vaccine.2015.12.037","article-title":"Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: a pilot randomized clinical trial","volume":"34","author":"Jamshed","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.lansea.2026.100873_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/21645515.2019.1565269","article-title":"The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity","volume":"15","author":"Gianchecchi","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.lansea.2026.100873_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/21645515.2018.1445446","article-title":"Seasonal influenza vaccine in immunocompromised persons","volume":"14","author":"Bosaeed","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.lansea.2026.100873_bib13","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/ajt.17151","article-title":"An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: a randomized controlled trial (CVIM 4 study)","volume":"22","author":"Bruminhent","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.lansea.2026.100873_bib14","first-page":"485","article-title":"Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use\u2014United states, 2010","volume":"59","year":"2010","journal-title":"Morb Mortal Wkly Rep"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:01:00Z","timestamp":1790370060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368226001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":14,"alternative-id":["S2772368226001587"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100873","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: a randomized controlled trial (2023)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100873"}}